| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |